Join
Live feed
·
INSIDERFilingvia Quantisnow
Vivos Therapeutics Inc. logo

SEC Form 4: Amman Bradford K. bought $5,290 worth of Common Stock (1,000 units at $5.29), increasing direct ownership by 100% to 2,000 units

ByQuantisnow·Wall Street's wire, on your screen.
VVOS· Vivos Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VVOS (Vivos Therapeutics Inc.) and more on Quantisnow.